Hematopoiesis is a dynamic process involving the up-and down-regulation of genes, as well as feedback loops that stimulate or suppress circulating cytokine concentrations. More complete pictures of the gene regulatory networks that control the production of the blood system have emerged with the advent of single-cell sequencing techniques and refinements to the capabilities of immunoassays. However, information about the regulatory networks of cytokines is still lacking. A novel mathematical technique (convergent cross-mapping, or CCM) allows for the extraction of causal relationships from data, which is of crucial importance for understanding these networks. To reconstruct the cytokine networks within the hematopoietic system we measured the concentrations of 62 cytokines, platelets, and thrombopoietin from an individual with cyclic thrombocytopenia (regular oscillations in the megakaryocytes and platelets) over 84 days. Using CCM, we identified 61 previously unreported cytokine relationships. Our approach is the first broad-scale investigation into causal relationships between cytokines in the blood and suggests a new paradigm for understanding how dynamic regulation occurs during hematopoiesis.
Introduction
The task of producing all of the body's blood cells is a monumental one, given that some 10 11 blood cells are derived from the hematopoietic stem cells (HSCs) every day through proliferation, differentiation, and maturation events. These processes are mediated by a cascade of cytokines responsible for amplifying or suppressing the various mechanisms that maintain basal blood cell numbers. Cytokines are a broad class of proteins that interact with blood cells at the receptor level and include stimulating and growth factors, chemoattractant chemokines, interleukins (ILs), and interferons (IFNs) that are crucial for eliciting functional hematological responses (immune-mediation, clotting, oxygen transport etc.). 1 Different cytokines have overlapping functions to provide a measure of flexibility to the hematopoietic system to mitigate potentially dangerous cases of deficiency or receptor interference. 2 To better understand how the hematopoietic system is maintained and responds to environmental or intrinsic stressors and/or pathological perturbations, the characterization of the relationships between these signalling proteins is necessary. Given recent advances in sequencing and computing power, the reconstruction of hematopoietic gene regulatory networks has been of increasing interest. [3] [4] [5] The identification of the regulatory organization of the blood has enabled a better elucidation of transcriptional hematological networks, 3, 5 and has led to the characterization of so-called 'hubs' (central nodes within the network graph that have many connections). 4 However, despite these advances, obtaining a complete picture of the cytokine regulation cascades that manage blood cell counts and functions remains difficult.
Generally speaking, the feedback interactions of the cytokine/hematopoietic system paradigm function without fail throughout life. However a number of hematological pathologies are known to result from broken cytokine networks and dysfunctional blood cell production mechanisms, including the rare oscillatory diseases like cyclic neutropenia, 6 and cyclic thrombocytopenia (CTP). [7] [8] [9] Recently, a 53-year-old male patient with CTP (cycle period of 40 days with platelet oscillations between 1 × 10 9 /L and > 400 × 10 9 /L) was found to have a heterozygous germline mutation resulting in a loss of of c-mpl function. 10 Previous spectral analysis identified statistically significant oscillations in platelet and neutrophil count and in and cytokine concentrations over time. 11 Using sampling data from this patient, we endeavored to uncover the many relationships between more than 60 cytokines and platelets using standard and state-of-the-art statistical and mathematical techniques.
CTP produces oscillations of fixed periods in the megakaryocytes and platelet lines, and of TPO concentrations. 9, 12 As we recently reported, during the manifestation of CTP, a variety of other cytokines exhibit oscillations with periods of varying length. 11 Ordinarily, entities that co-cycle with identical periods are likely to be found to be strongly correlated. Furthermore, standard measures of correlation are symmetric in the sense that if A is strongly correlated with B, it follows that B is strongly correlated with A. However, it is often the case that A and B are strongly coupled because the dynamics of B are strongly dependent on A (or vice versa), meaning that one variable inherits the period of the other through a one-way dynamical hierarchy. This cannot be uncovered by simply measuring the correlation of the two time series. To construct a dynamical hierarchy that contains more comprehensive information than standard statistical correlation, we sought an advanced approach able to uncover one-way dynamical relationships between different cytokines. We therefore turned to convergent cross-mapping (CCM), a methodology combining dynamical systems theory and causative analysis, pioneered by Sugihara et al. [13] [14] [15] [16] Beyond simply identifying cytokine relationships, CCM also allows us to arrange cytokines in a hierarchical regulatory network. Studying properties of the network itself reveals much about how information about hematopoietic functions is communicated within the blood. Periodogram analysis then suggests the timescales of these transmissions, a further piece of information that is hard to extract with CCM alone. Our approach combining correlation analysis, periodograms, and CCM is validated by the identification of hundreds of relationships corroborated in the literature. Fascinatingly, we further uncovered a fraction of unreported relationships, substantiating our approach and suggesting worthwhile subjects for future investigation.
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Results

Convergent cross-mapping reveals a robust network of interacting cytokines
The output of CCM analysis is a set of cross-maps (positive indicators that cytokine A has a causative effect on cytokine B) and a measure of the strength of this relationship (a real number between 0 and 1). Note that a cross-map is not a symmetric relationship; it is possible that A has a causative effect on B but that B does not have such an effect on A. Self cross-maps are considered redundant -therefore the data, which consisted of 63 objects (62 cytokines plus platelets), could yield a potential 63 × 62 = 3906 cross-maps. Our data consisted not only of cytokine levels but also measurements of the genes' RNA transcription levels. Therefore, we further divided cross-maps into those that occur at the level of transcription (meaning A has a causative influence on both B and its RNA precursor) and those that do not. Of these 3906 possibilities, we uncovered roughly 1200 that met the standard of successfully crossmapping two cytokines with Spearman rank-correlation on cross-mapping skill of p 0.05. We further filtered these results by requiring that the maximum cross-mapping skill S of at least one edge between the two cytokines exceeded the threshold S φ→ψ (24) > 0.8, where 24 is the total number of observations in the time series dataset. This left the 305 cross-maps pictured in Fig. 1 . For a lengthier discussion of CCM and why the threshold of S φ→ψ (24) > 0.8 was used, see the Supplementary Information.
Analyzing the graph structure of the cytokine-cytokine interaction networks reinforces our understanding of the robustness of the immune system, even during the perturbed hematopoiesis present in this individual. At minimum, 4 cytokines (e.g. IL12P40, IL17A,CD40L and TRAIL) must be completely removed from the system before the regulatory network is meaningfully disrupted, meaning information cannot flow from one given cytokine to any other cytokine (see Supplementary Information for extensive analysis of the network structure provided by CCM).
While a great number of cross-maps were found at the transcriptional level, the majority are not. The absence of a transcriptional cross-map can be caused for one of three reasons: 1) because noise in the data has lowered the CCM signal of interaction at the transcriptional level below our self-imposed confidence threshold, 2) because the cytokine being cross-mapped-to (target of an edge in Fig. 1) is not produced by blood cells (such as TPO, which is produced in the liver), or 3) because the interaction between the two cytokines is genuinely at an "environmental" (rather than transcriptional) level. Examples of these latter interactions involve the competition for limited resources, such as inactivation via heparan sulfate in the case of IL8 and FGFB, 17, 18 or an interaction between a cytokine and a cell type that produces the cross-mapped cytokine -for instance, apoptosis-inducing cytokines tend to cross-map other cytokines at this environmental level, likely because they are simply removing cytokine-producing cells from the blood.
Elucidating the presence and timescales of between-cytokine communication
As a comparative measure, we also investigated how RNA transcription and cytokine concentrations were statistically correlated (Fig. 2) . When detected, RNA expression was generally weakly correlated with cytokine concentrations in the blood, with some exception (cell surface integrins VCAM1/ICAM1 concentrations and PDGFBB gene expression, and HGF concentrations and TNFB gene expressions, for example). The general lack of information about how cytokines interact with gene expression when viewed through this lens stands in stark contrast to Fig. 1 , where CCM analysis revealed a much greater amount of interaction between plasma cytokine levels and gene expression.
To compare the cross-mapping results with the pairwise Pearson correlation results, we reinterpreted the network structure of Fig. 1 as a table similar to a more usual correlation matrix, as seen in Fig.  3 . Surprising differences between cytokine interactions are revealed: while certain clusters of correlated cytokines are found via convergent cross mapping to also have a causative effect on one another, other correlated clusters are almost entirely absent in the CCM picture. This could either be because these cytokines indeed have no direct causative effect on one another, and co-cycle due to forcing by some other Here, an edge is red if the interaction is at a transcriptional level (meaning the source cytokine crossmaps the RNA levels of the target cytokine) and blue otherwise. Blue interactions could mean that the CCM signal at the transcriptional is not sufficiently strong, or that the interaction between the cytokines happens at an environmental level, for instance being inactivated by identical chemical compounds, such as inactivation by heparan sulfate in FGFB and IL8.
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We have previously identified eight distinct cycling periods within the data (hereafter called "period classes"). 11 Restricting our analyses to those cytokines (and platelets) that exhibited these statistically significant oscillations, and grouping them according to period class (denoted by the red squares in Figure 3a) , we looked for strong positive (in phase) or negative (out of phase) correlations within each period class. The distinction of in or out of phase can be made by combining the spectral Lomb-Scargle analysis 11 and the correlation results of Figure 3b . We observed that the vast majority of correlations within each period class are positive, indicating that most cytokines within the same class are oscillating in phase, with the exception of the associations between BDNF/IL12P40, ICAM1/IL7, and ICAM1/RANTES, and all molecules within the 38.9565-day period class and TPO.
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is not symmetric (A crossmaps B does not imply B crossmaps A), a mark indicates that the cytokine along the vertical axis (horizontal cytokine names) has a causative influence on the cytokine along the horizontal axis (vertical cytokine names).
If this influence has a strong CCM signature at the transcriptional level, the mark is green. If the CCM signature is seen at the population/environmental level but not at the transcriptional level, the mark is purple.
positively pairwise correlated. However when a statistically significant relationship exists, leptin, IP10, TPO and IL12P40 are almost entirely negatively correlated with every other cytokine. While the full analysis revealed correlations between RANTES and IL7 in the second cluster, the period class crossmapping identified causal relationships between RANTES, IL7, and VCAM1/ICAM1, which were found to cluster in the fourth correlation group.
Exploiting period classes to expose novel causal relationship structures
Using our previous Lomb-Scargle results, 11 we explored the cross-maps between cytokines within period classes, displayed in Fig. 4 . Given the degree of pairwise correlations within each class, we anticipated the causal networks to be complete graphs (each node connected to every other by a unique edge). The 29.22 and 31.87 day classes almost achieve completeness, save for one or two edges (in the 29. 
Establishing novel cytokine relationships through CCM analysis
Of the 305 cross-maps identified using the S φ→ψ (24) > 0.8 as a minimal threshold, we identified 60 previously unknown relationships between cytokines (see Supplemental Data for a complete list of crossmaps and identification methodology, as well as citations from the literature for the known relationships uncovered by CCM). Thus 19.6% of the cross-maps identified through convergent cross-mapping with truncation at S φ→ψ (24) > 0. 8 have not previously been reported in the literature. These novel interactions are listed in Table 1 and include a variety of interleukins, and growth and necrosis factors. Although CCM analysis easily differentiates between scenarios in which a given cytokine A governs B and C without B and C interacting and those in which B directly interact with C, it is unable to differentiate the causal chain A → B → C from A → C with surety (see Supporting Information). We therefore include the minimum number of relationships that are already known (in the literature) to distinguish the proposed novelty. As the number of intervening known edges becomes larger, it becomes less plausible that this edge is a false positive, and therefore these are the relationships that merit future exploration the most. Viewed through a different lens, we may say that CCM is 80% accurate -that is, it indicates causal interactions which have been independently corroborated by previous research 80% of the time. To gauge whether CCM is really an effective method to untangle interactions from time-series data, we compared this measure of accuracy to direct Pearson correlations (interpreting pairs with ρ > 0.8 to represent true interactions, just as we require the CCM predictive strength at maximum library to be larger than 0.8), and also to the null constructed by drawing pairs of cytokines uniformly-at-random and then checking against the literature. In the null case, we selected 100 cytokine-cytokine pairs at random and compared them to the previous reports, finding that 37% percent of them were accurate, i.e., were corroborated by at least one experimental paper. The number of pairs with Pearson correlation ρ > 0.8 was 278, similar to the 305 found by CCM with the same cutoff criterion; however, only 58% of these were corroborated by the literature. By this metric, then, CCM does seem to offer a substantial increase in interaction-inference accuracy over traditional methods. Further, CCM offers information as to the directionality of reported interactions, as opposed to Pearson correlation, which is undirected by definition. Most of the novelties suggested by CCM occur twice, with one arrow in each direction. If the results of CCM are instead treated as an undirected graph, then 19 duplicates are removed, leaving 41 unconfirmed connections, and the accuracy increases to 87%.
Discussion
Buoyed by improvements to sequencing techniques and computational power, we are now beginning to understand how an intricate regulatory network of interacting cytokines and gene transcription in various cell lineages controls hematopoiesis. At present, a great deal of attention in this regard is paid to genetic regulation at the intracellular level. However a multitude of cytokines also transmit information as they coordinate both the production and function of the body's blood cells. Cytokine and blood cell concentrations fluctuate daily, but additional information about the dynamic nature of the hematopoietic system is fully revealed during pathological conditions. By leveraging information obtained during dynamical disease, we sought to establish the structure of the causal cytokine relationships that present in this patient with perturbed platelet homeostasis.
Our approach uncovered many previously corroborated cytokines relationships, which validates the methodology we employed. Most causal connections were found to be environmental rather than transcriptional, a conclusion mirrored in the standard Pearson correlation measurements that are much sparser than the full pairwise correlation matrix between cytokines. In a previous analysis, we identified 12 period classes of cytokines cycling with the same duration. Combining these classes with our correlation results allowed us to identify cytokines cycling in-and out-of-phase in a given class. However, the causal communication between cytokines only comes into focus when we constructed the cross-maps within each class. We established that the networks of each class were not complete, and identified "master" transmitters of information within most classes. Most notably, we revealed ∼1200 total successful cross-maps in the full dataset, with 305 cross-maps remaining after truncation at the S φ−→ψ (24) > 0.8 level of significance. Of these, we identified 61 previously unreported relationships that are strong candidates for future investigation. However, it would be unfair to say that the CCM analysis is somehow superior to the analysis based on statistical correlations. For example, when we plot the results of Fig. 1 in a table side-by-side with the correlation tables in Fig. 3 , it is clear that the output of CCM analysis is much sparser. Further, on its own, CCM contains no information about the period of cycling of a given cytokine or co-cycling BDNF  PDGFB  1  IL27  TNFB  1  FASL  FGFB  1  IL31  FGFB  1  FASL  IL9  1  IL31  TNFB  2  FASL  SCF  1  MCSF  IL9  1  FGFB  FASL  1  MIP1A  SCF  1  FGFB  IFNG  1  MIP1A  TRAIL  1  FGFB  IL13  1  MIP1B  SDF1A  1  FGFB  IL27  1  MIP1B  TGFA  1  FGFB  IL9  1  PDGFB  ICAM1  2  GROA  IFNG  1  PDGFB  IL12P40  2  ICAM1  PDGFB  1  PDGFB  VCAM1  1  IFNA  TGFA  1  PLTs  IL5  2  IFNG  FGFB  1  PLTs  PDGFB  1  IFNG  GROA  1  SCF  FASL  1  IFNG  IL9  1  SCF  TNFB  1  IL9  FASL  2  SDF1A  IL15  1  IL9  FGFB  1  TGFA  IFNA  1  IL9  IFNG  1  TGFA  IL17A  1  IL9  MCSF  1  TGFA  IL1A  1  IL9  TNFB  1  TGFA  MIP1B  1  IL12P40  PDGFB  1  TGFA  TNFA  1  IL12P40  PLTs  2  TGFA  VEGF  2  IL12P40  TPO  1  TNFB  IL27  2  IL13  FGFB  1  TNFB  IL31  1  IL15  SDF1A  1  TNFB  IL9  1  IL17A  TGFA  1  TNFB  SCF  2  IL17A  IL1A  1  TPO  IL12P40  1  IL18  FGFB  1  TRAIL  MIP1A  1  IL18  TNFB  1  VCAM1  PDGFB  2  IL27  FGFB  1  VCAM1  PLTs  2  VEGF  TGFA  1   Table 1 . Previously unreported relationships revealed through convergent cross-mapping. Of the ∼1200 causal relationships identified through convergent cross-mapping (see Supplementary Information for details), we identified 305 relationships by truncating the maximal cross-mapping skill with the minimal threshold of S φ→ψ (24) > 0.8. In addition, we have indicated the number of intervening cytokines along known pathways: as this number increases, the likelihood that the novel relation is an artifact of CCM analysis decreases. Pairs highlighted in light grey were identified by both CCM and direct Pearson correlation (with ρ > 0.8, see Supplementary Information). Of the 305 causal associations found by CCM, 60 are previously unreported (19.6%). The best candidates for future investigation are highlighted in dark grey/white text. Highlighted in medium grey are those identified by both methods that are also strong candidates for further study. A more thorough exploration of these novelties is provided in the Supplementary Material.
between cytokines, nor does it indicate whether a cross-mapping from A to B indicates up-regulation or down-regulation of B due to A. Notwithstanding these limitations, we were able to broadly assess causal cytokine relationships in the hematopoietic system, despite studying only a single person, given the rich sampling and highly dynamical nature of this individual's disease. Future work should incorporate both healthy individuals and a wider sample of people with similar dynamic pathologies, including cyclic neutropenia and chronic myeloid leukemia. This study nonetheless presents a new and powerful way to study the cytokinetic (and genetic) connections within the blood, and suggests that there is much more to discover than can be found using standard statistical means.
Methods
Cell counts and cytokine assays
Blood samples were drawn every 3-4 days for 84 days total (24 samples total over two cycles) from a 53-year old individual with a previously-described presentation of cyclic thrombocytopenia related to a heterozygous germline mutation resulting in the loss of c-mpl function. Blood transcriptome profiles were performed on whole blood using 3SEQ (3'-end RNA sequencing for expression quantification). Platelet poor plasma was isolated to measure thrombopoietin concentration via ELISA and a panel of 62 cytokines using a Luminex immunoassay.
Determining causal relationships using convergent cross-mapping
For each of the measured 62 cytokines and their gene expression data, as well as platelets and thrombopoietin, we computed the cross-mapping to all other platelets/cytokines applied Sugihara et al.'s 13 convergent cross-mapping (CCM) approach. CCM was developed to determine causal relationships in time series without reference to the usual statistical correlation. 16 A detailed description of the mathematical foundations of convergent cross-mapping and a description of the algorithm are provided in the Supplementary Information. For each of the 63 × 62 = 3906 (self-maps are redundant) total possible cross-maps, we calculated the cross-mapping skill as a function of library length L (which cannot exceed 24, the total number of measurements) and embedding dimension E according to the algorithm described in the Supplementary Information. We then performed Spearman rank-correlation on cross-mapping skill and L for each cross-mapping to isolate those that showed convergent cross-mapping (by keeping only those with p 0.05). This subset of cross-maps was then examined by eye to remove cases where the Spearman correlation assigned a p-value less than 0.05, but the cross-mapping skill was not sufficiently monotonic in L to ensure accurate forecasting at differing library lengths.
Correlations between measures
To understand the statistical associations between platelets, thrombopoietin, and the 62 cytokines and their genes, we quantified their pairwise Pearson correlations using the cor function in R 20 and plotted the results with corrplot. 19 Hierarchical clustering according to dissimilarity was applied to group statistically similar cytokines.
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